Published in Toxicol Sci on June 13, 2010
Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol (2011) 1.73
Mechanisms of lead and manganese neurotoxicity. Toxicol Res (Camb) (2013) 1.09
Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism. PLoS One (2012) 0.92
Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington's disease confirms a deficit in manganese accumulation. Neurotoxicology (2011) 0.87
A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease. Hum Mol Genet (2014) 0.84
Cellular fura-2 manganese extraction assay (CFMEA). Curr Protoc Toxicol (2011) 0.84
Cellular manganese content is developmentally regulated in human dopaminergic neurons. Sci Rep (2014) 0.82
Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT-Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment. J Toxicol (2012) 0.80
Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. Metallomics (2015) 0.80
BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity. J Neurochem (2014) 0.79
Sudden sensorineural hearing loss and polymorphisms in iron homeostasis genes: new insights from a case-control study. Biomed Res Int (2015) 0.77
Expression of RNAs Coding for Metal Transporters in Blood of Patients with Huntington's Disease. Neurochem Res (2015) 0.75
Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature (1997) 9.98
Huntington's disease. Lancet (2007) 6.82
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science (2001) 5.28
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell (2006) 4.53
Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A (1998) 4.07
Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet (2000) 3.87
Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet (2009) 3.59
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
Molecular pathways to neurodegeneration. Nat Med (2004) 2.94
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol (2005) 2.57
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A (2006) 2.35
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci (1993) 2.27
Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol (2007) 2.17
Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol (2005) 1.83
ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol Pharmacol (2006) 1.76
An error model for protein quantification. Bioinformatics (2007) 1.72
Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol Pharmacol (2008) 1.69
Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett (2001) 1.68
Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res (1999) 1.68
Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci (2007) 1.66
The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis (1998) 1.65
Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet (2000) 1.45
Mitochondria in Huntington's disease. Biochim Biophys Acta (2009) 1.41
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia (2007) 1.40
Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease. J Neurosci (2009) 1.40
Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Curr Opin Neurol (2008) 1.40
Glutamate and astrocytes--key players in human mesial temporal lobe epilepsy? Epilepsia (2008) 1.38
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. Pharmacol Res (2005) 1.35
Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem (2005) 1.31
Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect (2005) 1.30
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum Mol Genet (2007) 1.29
Manganese (Mn) transport across the rat blood-brain barrier: saturable and transferrin-dependent transport mechanisms. Brain Res Bull (1994) 1.25
Metals ions and neurodegeneration. Biometals (2007) 1.24
Alteration of serum concentrations of manganese, iron, ferritin, and transferrin receptor following exposure to welding fumes among career welders. Neurotoxicology (2005) 1.24
Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol (2009) 1.23
Manganese accumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol Trace Elem Res (2002) 1.23
Phosphate binding to alkaline phosphatase. Metal ion dependence. J Biol Chem (1970) 1.23
Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J Neurochem (2009) 1.23
Iron overload following manganese exposure in cultured neuronal, but not neuroglial cells. Brain Res (2001) 1.21
Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro. Toxicol Appl Pharmacol (2005) 1.17
Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease. J Neurosci (2007) 1.13
Metals and neurotoxicology. J Nutr (2007) 1.13
Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Neurobiol Dis (2008) 1.12
Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicol Sci (2006) 1.11
Genes and the environment in neurodegeneration. Biosci Rep (2006) 1.11
Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. Neurotoxicology (2006) 1.11
Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS J (2006) 1.11
Globus pallidus: a target brain region for divalent metal accumulation associated with dietary iron deficiency. J Nutr Biochem (2004) 1.09
Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death. Toxicol Sci (2007) 1.09
Mechanisms of copper ion mediated Huntington's disease progression. PLoS One (2007) 1.08
Mutant huntingtin enhances excitotoxic cell death. Mol Cell Neurosci (2001) 1.08
A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol Sci (2006) 1.05
In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease. J Neurosci (2009) 1.05
Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci (2008) 1.02
Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Exp Neurol (2001) 1.02
Increased basal ganglia iron levels in Huntington disease. Arch Neurol (1999) 1.01
Nutrition versus toxicology of manganese in humans: evaluation of potential biomarkers. Neurotoxicology (1999) 1.00
Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure. J Neurochem (2009) 1.00
Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology (2005) 0.99
Huntingtin-interacting proteins, HIP14 and HIP14L, mediate dual functions, palmitoyl acyltransferase and Mg2+ transport. J Biol Chem (2008) 0.98
Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. Hum Mol Genet (2007) 0.97
Alterations in cellular IRP-dependent iron regulation by in vitro manganese exposure in undifferentiated PC12 cells. Brain Res (2003) 0.96
Temporal responses in the disruption of iron regulation by manganese. J Neurosci Res (2006) 0.94
Transferrin is required for normal distribution of 59Fe and 54Mn in mouse brain. J Neurol Sci (1999) 0.93
Concentrations of physiologically important metal ions in glial cells cultured from chick cerebral cortex. Neurochem Res (1988) 0.93
Intracellular localization and subsequent redistribution of metal transporters in a rat choroid plexus model following exposure to manganese or iron. Toxicol Appl Pharmacol (2008) 0.92
Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease. Toxicol Sci (2010) 0.90
Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington's disease caudate nucleus. J Neurochem (1986) 0.88
Reducing arginase activity via dietary manganese deficiency enhances endothelium-dependent vasorelaxation of rat aorta. Exp Biol Med (Maywood) (2004) 0.85
Binding of manganese and transferrin in rat serum. Biochim Biophys Acta (1970) 0.79
Effects of Ca(II) ions on Mn(II) dynamics in chick glia and rat astrocytes: potential regulation of glutamine synthetase. Neurochem Res (1994) 0.77
Loss of glutamine synthetase activity in the brain in Huntington's disease. Lancet (1981) 0.76
Levels and sub-cellular distribution of physiologically important metal ions in neuronal cells cultured from chick embryo cerebral cortex. Neurochem Res (1988) 0.76
Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature (2008) 3.68
ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell (2006) 3.39
Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci U S A (2005) 2.90
Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci (2008) 2.49
Manganese neurotoxicity may underlie the association between early life iron deficiency and impaired spatial cognition in neonatal piglets. J Nutr (2013) 2.16
Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction. PLoS Biol (2006) 2.12
Nutritional aspects of manganese homeostasis. Mol Aspects Med (2005) 2.03
Manganese neurotoxicity. Ann N Y Acad Sci (2004) 1.94
Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol (2005) 1.83
Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol (2011) 1.73
Mefloquine neurotoxicity is mediated by non-receptor tyrosine kinase. Neurotoxicology (2011) 1.56
Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol (2003) 1.55
Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromolecular Med (2009) 1.54
Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology (2008) 1.53
The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brain. Toxicology (2011) 1.51
Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proc Natl Acad Sci U S A (2009) 1.38
Neonatal iron deficiency results in irreversible changes in dopamine function in rats. J Nutr (2003) 1.33
Developmental neuropathology of environmental agents. Annu Rev Pharmacol Toxicol (2004) 1.28
Oxidative stress in MeHg-induced neurotoxicity. Toxicol Appl Pharmacol (2011) 1.28
Anticholinesterase toxicity and oxidative stress. ScientificWorldJournal (2006) 1.27
Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther (2006) 1.26
Speciation of manganese in cells and mitochondria: a search for the proximal cause of manganese neurotoxicity. Neurotoxicology (2006) 1.25
Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet (2010) 1.23
Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol (2009) 1.23
Manganese accumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol Trace Elem Res (2002) 1.23
Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J Neurochem (2009) 1.23
Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ Toxicol Pharmacol (2005) 1.22
Down-regulation of early ionotrophic glutamate receptor subunit developmental expression as a mechanism for observed plasticity deficits following gestational exposure to benzo(a)pyrene. Neurotoxicology (2007) 1.22
Manganese neurotoxicity and glutamate-GABA interaction. Neurochem Int (2003) 1.20
Glutathione modulation influences methyl mercury induced neurotoxicity in primary cell cultures of neurons and astrocytes. Neurotoxicology (2006) 1.20
Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol Sci (2007) 1.20
Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occup Environ Med (2012) 1.17
Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci (2011) 1.16
In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect (2010) 1.16
Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicology (2008) 1.15
Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity. Exp Neurol (2007) 1.15
SyM-BBB: a microfluidic Blood Brain Barrier model. Lab Chip (2013) 1.12
ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. Dev Cell (2011) 1.12
SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans. PLoS One (2009) 1.11
Manganese exposure among smelting workers: blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers (2009) 1.11
DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction. ACS Chem Neurosci (2012) 1.11
Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicol Sci (2006) 1.11
Roles of glutamine in neurotransmission. Neuron Glia Biol (2011) 1.11
Globus pallidus: a target brain region for divalent metal accumulation associated with dietary iron deficiency. J Nutr Biochem (2004) 1.09
Manganese exposure and induced oxidative stress in the rat brain. Sci Total Environ (2004) 1.08
Neurobehavioral analysis of developmental iron deficiency in rats. Behav Brain Res (2002) 1.08
Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology (2004) 1.08
Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol Appl Pharmacol (2007) 1.07
Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia. J Neurochem (2009) 1.06
Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology (2011) 1.06
Role of astrocytes in brain function and disease. Toxicol Pathol (2010) 1.06
DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model. Neurobiol Dis (2011) 1.05
A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol Sci (2006) 1.05
Methylmercury induces acute oxidative stress, altering Nrf2 protein level in primary microglial cells. Toxicol Sci (2010) 1.05
The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem Int (2006) 1.05
Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes. J Neurochem (2009) 1.04
Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. Chem Rev (2009) 1.04
Prenatal exposure to benzo(a)pyrene impairs later-life cortical neuronal function. Neurotoxicology (2008) 1.03
Determining the oxidation states of manganese in NT2 cells and cultured astrocytes. Neurobiol Aging (2005) 1.03
Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes. Brain Res (2006) 1.03
Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes. Brain Res Mol Brain Res (2005) 1.03
Manganese Is Essential for Neuronal Health. Annu Rev Nutr (2015) 1.03
Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci (2008) 1.02
The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter. J Neurochem (2008) 1.02
Inhibition of DAT function attenuates manganese accumulation in the globus pallidus. Environ Toxicol Pharmacol (2007) 1.01
Methylmercury-induced reactive oxygen species formation in neonatal cerebral astrocytic cultures is attenuated by antioxidants. Brain Res Mol Brain Res (2003) 1.01
Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure. J Neurochem (2009) 1.00
Prenatal polycyclic aromatic hydrocarbon exposure leads to behavioral deficits and downregulation of receptor tyrosine kinase, MET. Toxicol Sci (2010) 1.00
Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology (2002) 1.00
Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures. Brain Res (2008) 0.99
Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem Int (2012) 0.99
Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology (2005) 0.99
Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol Sci (2007) 0.99
Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicol Sci (2009) 0.98
Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist. Toxicol Appl Pharmacol (2009) 0.98
Manganese (Mn) and iron (Fe): interdependency of transport and regulation. Neurotox Res (2009) 0.98
Modulation of cholinergic systems by manganese. Neurotoxicology (2007) 0.98
Methylmercury-induced alterations in astrocyte functions are attenuated by ebselen. Neurotoxicology (2011) 0.98
Measurement of isoprostanes as markers of oxidative stress in neuronal tissue. Curr Protoc Toxicol (2009) 0.97
Leaching of trace elements from biological tissue by formalin fixation. Biol Trace Elem Res (2007) 0.97
Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons. Neurotoxicology (2010) 0.96
GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes. J Biol Chem (2012) 0.96
Free radical formation in cerebral cortical astrocytes in culture induced by methylmercury. Brain Res Mol Brain Res (2004) 0.96
Retracted Polymorphic ventricular tachycardia and abnormal Ca2+ handling in very-long-chain acyl-CoA dehydrogenase null mice. Am J Physiol Heart Circ Physiol (2007) 0.96